397 related articles for article (PubMed ID: 14515341)
1. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
[TBL] [Abstract][Full Text] [Related]
2. Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression.
Rothman RB; Jayanthi S; Cadet JL; Wang X; Dersch CM; Baumann MH
Ann N Y Acad Sci; 2004 Oct; 1025():151-61. PubMed ID: 15542713
[TBL] [Abstract][Full Text] [Related]
3. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
4. Rat brain serotonin neurones that express neuronal nitric oxide synthase have increased sensitivity to the substituted amphetamine serotonin toxins 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
De Silva DJ; French SJ; Cheung NY; Swinson AK; Bendotti C; Rattray M
Neuroscience; 2005; 134(4):1363-75. PubMed ID: 16054768
[TBL] [Abstract][Full Text] [Related]
5. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
Xie T; Tong L; McLane MW; Hatzidimitriou G; Yuan J; McCann U; Ricaurte G
Neuropsychopharmacology; 2006 Dec; 31(12):2639-51. PubMed ID: 16452989
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations.
Bowyer JF; Young JF; Slikker W; Itzak Y; Mayorga AJ; Newport GD; Ali SF; Frederick DL; Paule MG
Neurotoxicology; 2003 Jun; 24(3):379-90. PubMed ID: 12782103
[TBL] [Abstract][Full Text] [Related]
7. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
[TBL] [Abstract][Full Text] [Related]
8. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
Baumann MH; Ayestas MA; Rothman RB
Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
[TBL] [Abstract][Full Text] [Related]
9. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.
Barker EL; Kimmel HL; Blakely RD
Mol Pharmacol; 1994 Nov; 46(5):799-807. PubMed ID: 7969065
[TBL] [Abstract][Full Text] [Related]
10. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
[TBL] [Abstract][Full Text] [Related]
11. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain.
Clausing P; Newport GD; Bowyer JF
J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806
[TBL] [Abstract][Full Text] [Related]
12. (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane.
Wang X; Baumann MH; Xu H; Morales M; Rothman RB
J Pharmacol Exp Ther; 2005 Sep; 314(3):1002-12. PubMed ID: 15937150
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
Schuldiner S; Steiner-Mordoch S; Yelin R; Wall SC; Rudnick G
Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417
[TBL] [Abstract][Full Text] [Related]
14. Increased behavioural activity of rats in forced swimming test after partial denervation of serotonergic system by parachloroamphetamine treatment.
Häidkind R; Eller M; Kask A; Harro M; Rinken A; Oreland L; Harro J
Neurochem Int; 2004 Oct; 45(5):721-32. PubMed ID: 15234115
[TBL] [Abstract][Full Text] [Related]
15. Acute and chronic effects of nicotine on serotonin uptake in prefrontal cortex and hippocampus of rats.
Awtry TL; Werling LL
Synapse; 2003 Dec; 50(3):206-11. PubMed ID: 14515338
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB).
Li Q; Ma L; Innis RB; Seneca N; Ichise M; Huang H; Laruelle M; Murphy DL
J Pharmacol Exp Ther; 2004 Feb; 308(2):481-6. PubMed ID: 14610240
[TBL] [Abstract][Full Text] [Related]
17. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304).
Ansah TA; Ramamoorthy S; Montañez S; Daws LC; Blakely RD
J Pharmacol Exp Ther; 2003 Jun; 305(3):956-65. PubMed ID: 12626658
[TBL] [Abstract][Full Text] [Related]
18. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.
Zhu CB; Hewlett WA; Feoktistov I; Biaggioni I; Blakely RD
Mol Pharmacol; 2004 Jun; 65(6):1462-74. PubMed ID: 15155839
[TBL] [Abstract][Full Text] [Related]
19. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.
Lew R; Weisenberg B; Vosmer G; Seiden LS
Synapse; 1997 May; 26(1):36-45. PubMed ID: 9097403
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
